Enanta Pharmaceuticals (ENTA) Cash & Equivalents Growth (3y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -51.77% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 24.73% |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -28.55% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 13.33% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -16.07% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 21.66% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.88% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 36.53% |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - | -21.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.85% |
| Dec 31, 2025 | -3.93% |
| Sep 30, 2025 | -9.79% |
| Jun 30, 2025 | 16.46% |
| Mar 31, 2025 | 13.68% |
| Dec 31, 2024 | -5.22% |
| Sep 30, 2024 | -13.34% |
| Jun 30, 2024 | 98.11% |
| Mar 31, 2024 | -6.25% |
| Dec 31, 2023 | -10.17% |
| Sep 30, 2023 | -0.67% |
| Jun 30, 2023 | -1.59% |
| Mar 31, 2023 | -0.52% |
| Dec 31, 2022 | 15.28% |
| Sep 30, 2022 | -4.95% |
| Jun 30, 2022 | -32.97% |
| Mar 31, 2022 | -27.15% |
| Dec 31, 2021 | 10.03% |
| Sep 30, 2021 | -3.62% |
| Jun 30, 2021 | -52.33% |
| Mar 31, 2021 | 4.84% |
| Dec 31, 2020 | -6.80% |
| Sep 30, 2020 | 9.88% |
| Jun 30, 2020 | 64.92% |
| Mar 31, 2020 | 57.00% |
| Dec 31, 2019 | 10.15% |
| Sep 30, 2019 | 45.66% |
| Jun 30, 2019 | 56.05% |
| Mar 31, 2019 | 23.45% |
| Dec 31, 2018 | 17.17% |
| Sep 30, 2018 | 43.28% |
| Jun 30, 2018 | 28.88% |
| Mar 31, 2018 | 37.49% |
| Dec 31, 2017 | 25.86% |
| Sep 30, 2017 | 28.85% |
| Jun 30, 2017 | -5.49% |
| Mar 31, 2017 | 2.00% |
| Dec 31, 2016 | 67.01% |
| Sep 30, 2016 | 23.23% |
| Jun 30, 2016 | 9.51% |
| Mar 31, 2016 | -8.87% |
| Dec 31, 2015 | 30.64% |
| Sep 30, 2015 | 27.38% |
| Jun 30, 2015 | 71.11% |
| Mar 31, 2015 | 7.55% |